DIWALI SPECIAL

25% OFF + 1-Yr NT Prime FREE !

Use
00h : 00m : 00s
Claim Offer →
logo
Market statusData NSENot investment advice
MANIPAL HEALTH ENTERPRI L

MANIPAL HEALTH ENTERPRI L Latest Share Price (MANIPALHOS)

₹646.70
10.55−1.61%
Overall Score42/100
Day range643
₹646.70
657
52-week597
₹646.70
815
Above low+8.3%
Below high20.7%
Range position23%
Open657.25
Prev Close657.25
Bid646.67142
Ask646.73100

TODAY IN ONE LINE

MANIPALHOS fell 1.6%, lagging Nifty's 2.0% move.

With a market cap of ₹85,012.83 Cr., it trades at a P/E of N/A. Track live valuations, technical indicators, and peers comparison below. Check delivery conviction and recent filings to build your view.

Volume355.3K−59%vs 20D avg
Price Band20
Lower Band500.35
Upper Band750.45
Tick Size0.05
Daily Volatility1.13%
Annualised Vol21.59%
Market Cap₹85,012.83 Cr.
Promoter65.8%
Face Value—
Fwd P/E—
PEG—
EV/EBITDA—
P/S—
ROA—
Beta—
Div Payout—
THE STOCK SCORE
Overall Score42/100
Updated 27 Aug

How good is this company?

Overall performance across 5 key dimensions.

Each card tappable → shows formula + inputs
FLAGS & NEWS

MANIPAL HEALTH ENTERPRI L flags & news 

Key strengths, potential risks, and recent updates.

✅ 3 green flags🚩 0 red flags

Green Flags

  • ●High Promoter HoldingPromoters hold 65.8% skin-in-the-game
  • ●Virtually Debt-FreeVery low Debt-to-Equity of 0.00x
  • ●Zero Pledge RiskNo recent active promoter pledging found

Red Flags

No red flags identified

Latest MANIPAL HEALTH ENTERPRI L News

THE CHANGELOG

What changed recently?

Recent events, corporate actions, and announcements.

06 NOV 2026
corporate
Analysts/Institutional Investor Meet/Con. Call Updates - Manipal Health Enterprises Limited has informed the Exchange about Schedule of meet
View PDF
04 NOV 2026
corporate
Press Release - Manipal Health Enterprises Limited has informed the Exchange regarding a press release dated Novembe...
View PDF
04 NOV 2026
corporate
Updates - Manipal Health Enterprises Limited has informed the Exchange regarding 'Press Release'.
View PDF
04 NOV 2026
corporate
Agreements - Manipal Health Enterprises Limited has informed the Exchange about Agreements
View PDF
🔒Prime: full history + alerts on this stock
Valuation

MANIPAL HEALTH ENTERPRI L valuation: P/E, P/B and sector benchmarks.

Twelve years of multiples investors have paid for MANIPAL HEALTH ENTERPRI L, framed against the sector median so the premium or discount is obvious at a glance.

Key MetricsMarket + reported · 06 Nov 2026Consolidated

Market-priced ratios use the latest available quote; accounting metrics use the latest reported filing. Compare values with matched peers and the company's own history.

Valuation

Valuation

Market Cap
₹85,012.83 Cr.
P/E Ratio
—
P/B Ratio
—
EPS
₹1.76
Profitability

Profitability

ROE
—
ROCE
—
Net Margin
—
Op Margin
—
Growth

Growth

EPS YoY
—
Revenue YoY
—
Qtr Sales
—
Qtr Profit
—
Financial Health

Financial Health

Debt / Equity
—
Book Value
—
Div Yield
—
Promoter Holding
65.8%
Technicals

MANIPAL HEALTH ENTERPRI L technical analysis: indicators, pivots and CPR.

Latest RSI, MACD and moving-average signals plus the latest pivot and Central Pivot Range levels for MANIPAL HEALTH ENTERPRI L — derived from the latest tape, not yesterday's close.

MANIPAL HEALTH ENTERPRI L last traded at ₹646.7 with an intraday range of ₹643.1–₹657.35 — latest indicator, pivot and CPR signals below.

Last updated: 9 November 2026, 4:08 pm IST

Pivot points

Standard pivot — most widely referenced.

Pivot levels · Classic

Last: ₹646.70
LevelPrice (₹)Distance% Δ
R4683.50+36.80+5.69%
R3669.25+22.55+3.49%
R2663.30+16.60+2.57%
R1655.00+8.30+1.28%
PIVOT649.052.350.36%
CURRENT646.70——
S1640.75-5.95-0.92%
S2634.80-11.90-1.84%
S3626.50-20.20-3.12%
S4612.25-34.45-5.33%
CPR Levels
Support
Resistance
S4
S3
S2
S1
| CPR |
BC: 647.88P: 649.05TC: 650.23
R1
R2
R3
R4
indicator
LTP: 646.70
PDH: 675.10
PDL: 646.05
● Market Sentiment

MANIPALHOS is trading Below CPR, indicating Bearishness

● CPR Width

CPR is Average

● Opening Range

Day's range: ₹647.15–₹657.35

● Price Position

Trading Inside opening range

Financials

MANIPAL HEALTH ENTERPRI L financials: P&L, balance sheet, cash flow, ratios.

Reported annual and quarterly results for MANIPAL HEALTH ENTERPRI L — consolidated or standalone — with margins, YoY growth and key ratios inline.

MANIPAL HEALTH ENTERPRI L reports its full P&L, balance sheet, cash flow and ratios on this page — current market capitalisation of ₹85,012.83 Cr. and reported EPS of ₹1.76.

iTap any row for a plain-English meaning▲▼Change vs a year ago — green means the move is healthy for that line, red means it isn’tDerivedCalculated by us, not reported directly
all values in ₹ Cr unless marked % / x / ₹ · fiscal-period end shown · reported figures via Stockezee financials API · annual results may be audited; quarterly results may be unaudited or limited-review
Segment Analysis

MANIPAL HEALTH ENTERPRI L segment analysis : revenue and profit mix.

Disclosed business segments at MANIPAL HEALTH ENTERPRI L with their share of revenue and profit, switchable between consolidated and standalone reporting.

MANIPAL HEALTH ENTERPRI L discloses revenue and profit across multiple business segments — toggle between consolidated and standalone views to see the mix.

Segment-wise Financial Analysis

Thesis

The Bull, Bear, and Flip case for MANIPAL HEALTH ENTERPRI L.

Our AI distills the core fundamental drivers supporting MANIPAL HEALTH ENTERPRI L, the risks that threaten it, and the quantitative conditions that could weaken the thesis.

bull case

What you're getting.

No strengths or opportunities on record.

bear case

Key Risks.

No weaknesses or threats on record.

flip conditions

Flip Conditions.

  • Reassess if quarterly profit growth turns negative for two consecutive quarters. The bull case relies on compounding earnings.

Shareholding

MANIPAL HEALTH ENTERPRI L shareholding pattern: promoters, FII, DII and public.

Quarter-on-quarter ownership shifts in MANIPAL HEALTH ENTERPRI L — who is buying, who is exiting, and which institutions hold the largest positions.

Shareholding Pattern

Annual • Sep 2026

Public17.23%↓1.58%
Promoter65.80%
Promoters6.28%
FII3.50%↓0.15%
DII7.18%↑1.72%

Ownership Distribution

Retail & Public
17.23%
Promoter Foreign
65.80%
Promoters
6.28%
Foreign Institutions
3.50%
Domestic Institutions
7.18%

Category Trends

Foreign Institutions Breakdown
Total Holding: 3.50%
Net Change: -0.15%
Category Total3.50%
Total Holding3.50%
Net Change-0.15%
Aggregate Data
Institution Name
Trend (Last 6)
Holding %
QoQ Change
YoY ChangePeriod

Foreign Institutions: 3.50%

Individual institutional breakdown is not disclosed by the company, but aggregate holding data is shown above.

💡 This category has 3.50% total holding without detailed institution-wise disclosure
Peers

MANIPAL HEALTH ENTERPRI L peer comparison — same-sector benchmarks.

Same-sector listed peers ranked on P/E, market cap, dividend yield and growth — MANIPAL HEALTH ENTERPRI L is highlighted for quick read-across.

Quick Compare

Largest by Market Cap
MANIPAL HEALTH ENTERPRI L
₹85,012.83 Cr
Best Profit Growth
SHUKRA PHARMACEUTICALS L
742.72 %
Highest Dividend Yield
JENBURKT PHARMACEUTICAL L
2.20 %

Peer Comparison

Company Name
09 · Chart Patterns

MANIPAL HEALTH ENTERPRI L chart patterns: breakouts, tops and bottoms.

Auto-detected classical chart patterns for MANIPAL HEALTH ENTERPRI L — Double Top/Bottom, Head & Shoulders, Triple Bottom and more — with break levels, targets and quality scores across Intraday, Daily and Weekly timeframes.

Delivery Conviction

MANIPAL HEALTH ENTERPRI L delivery volume — last 20 sessions of conviction.

Daily traded volume and delivery percentage for MANIPAL HEALTH ENTERPRI L over 20 sessions — the gap between intraday flipping and genuine accumulation.

Latest session delivery in MANIPAL HEALTH ENTERPRI L stood at 50.6% of traded volume, against a 20-day average of 54.2%.

Avg Delivery (20D)54.2%-3.5 ppt latest vs avg
Highest Delivery79.2%on 27 Oct
Avg Volume (20D)8.73 L20-day run-rate
Conviction Trend↓ Weakening-3.5 ppt latest read
Volume & Delivery · last 20 sessions
Exchange Filings & Investor Updates

MANIPAL HEALTH ENTERPRI L announcements: results, concalls, ratings, M&A.

Filings MANIPAL HEALTH ENTERPRI L sent to the exchanges, sequenced as they hit the tape — concall transcripts, results, credit ratings and presentations.

MANIPAL HEALTH ENTERPRI L files concall transcripts, results, credit ratings and corporate-action notices on the NSE and BSE exchange portals — latest 33 documents below.

  1. 06 Nov 2026Analysts/Institutional Investor Meet/Con. Call UpdatesView PDF

    Analysts/Institutional Investor Meet/Con. Call Updates

    Manipal Health Enterprises Limited has informed the Exchange about Schedule of meet

  2. 04 Nov 2026Press ReleaseView PDF

    Press Release

    Manipal Health Enterprises Limited has informed the Exchange regarding a press release dated November 04, 2026, titled "Press Release - Intimation…

  3. 04 Nov 2026UpdatesView PDF

    Updates

    Manipal Health Enterprises Limited has informed the Exchange regarding 'Press Release'.

  4. 04 Nov 2026AgreementsView PDF

    Agreements

    Manipal Health Enterprises Limited has informed the Exchange about Agreements

  5. 30 Oct 2026Action(s) taken or orders passedView PDF

    Action(s) taken or orders passed

    Manipal Health Enterprises Limited has informed the Exchange about Action(s) taken or orders passed

Corporate Actions

MANIPAL HEALTH ENTERPRI L dividend history, splits and bonus issues.

Every dividend, stock split and bonus issue MANIPAL HEALTH ENTERPRI L has declared, sequenced by announce and record date.

MANIPAL HEALTH ENTERPRI L corporate-action history below covers all declared dividends, stock splits and bonus issues recorded with NSE and BSE.

About the Company

About MANIPAL HEALTH ENTERPRI L: business, sector, key facts.

What MANIPAL HEALTH ENTERPRI L does, where it operates, the people running it, and the numbers that describe the entity behind the ticker.

MANIPAL HEALTH ENTERPRI L is a listed Indian equity.

MANIPALHOS
Listed Equity

MANIPAL HEALTH ENTERPRI L

company facts
Employees—
Sector—
Headquarters—
Market Cap₹85,012.83 Cr.
Listed OnNSE · BSE
§ ∞ · Plainly Answered

Questions investors ask about MANIPAL HEALTH ENTERPRI L (MANIPALHOS).

Quick answers grounded in this page's data — price action, fundamentals, ratios and ownership.

01What is the current share price of MANIPAL HEALTH ENTERPRI L (MANIPALHOS)?

The current share price of MANIPAL HEALTH ENTERPRI L (MANIPALHOS) is ₹646.70. Today, the stock has declined by ₹10.55 (1.61%), trading in a range of ₹643.10 to ₹657.35. The stock opened at ₹657.25 with a trading volume of 3,55,251 shares.

02What is the 52-week high and low price of MANIPAL HEALTH ENTERPRI L stock?

The 52-week high price of MANIPAL HEALTH ENTERPRI L (MANIPALHOS) is ₹815.00, while the 52-week low is ₹597.00. Currently trading at ₹646.70, the stock is 8.32% above its 52-week low and 20.65% below its 52-week high. These levels help investors understand the stock's price volatility and trading range over the past year.

03What is the dividend yield of MANIPAL HEALTH ENTERPRI L and when is the next dividend?

MANIPAL HEALTH ENTERPRI L offers a dividend yield of 0%, which means for every ₹100 invested at the current price of ₹646.70, you can expect to receive approximately ₹0.00 annually as dividends. For information about the next dividend announcement and ex-dividend date, please check the company's official announcements or visit the BSE/NSE websites.

04How is MANIPAL HEALTH ENTERPRI L stock performing today in the market?

MANIPAL HEALTH ENTERPRI L stock opened at ₹657.25 and is currently trading at ₹646.70, showing a decline of ₹10.55 (1.61%). The intraday high is ₹657.35 and low is ₹643.10. The trading volume stands at 3,55,251 shares, indicating moderate market participation today.

05What is the market capitalization of MANIPAL HEALTH ENTERPRI L?

MANIPAL HEALTH ENTERPRI L has a market capitalization of ₹85,012.83 Cr., making it a mid-cap company. Market cap is calculated by multiplying the current stock price (₹646.70) by the total number of outstanding shares. This metric helps investors understand the company's size, stability, and investment risk profile.

06What is the ROE and ROCE of MANIPAL HEALTH ENTERPRI L?

MANIPAL HEALTH ENTERPRI L has a Return on Equity (ROE) of 0% and Return on Capital Employed (ROCE) of 0%. ROE measures how efficiently the company generates profits from shareholders' equity, while ROCE indicates how well the company uses its capital to generate profits. These returns may need improvement for better profitability. Higher percentages generally indicate better financial performance.

07Which sector and industry does MANIPAL HEALTH ENTERPRI L belong to?

MANIPAL HEALTH ENTERPRI L operates in the broader sector and belongs to the its industry. The company competes with other players in this space and its performance is influenced by sector-specific trends, regulatory changes, and market dynamics. Understanding the sector helps investors assess growth potential, cyclical patterns, and industry-specific risks that may impact the stock's performance.

08What is the sales and profit growth of MANIPAL HEALTH ENTERPRI L?

MANIPAL HEALTH ENTERPRI L has reported a sales growth of 0% and profit growth of 0%. The company may be facing growth challenges or operating in a mature market. Consistent growth over multiple quarters is a positive indicator for long-term investors. Compare these growth rates with industry peers for better perspective.

Disclaimer

The data, ratios and commentary about MANIPAL HEALTH ENTERPRI L (MANIPALHOS) on this page are published for educational and informational purposes only and are not investment, legal or tax advice. StockeZee is not a SEBI-registered investment adviser, research analyst or portfolio manager, and no content here should be construed as a recommendation to buy, hold or sell any security. Live and historical market data may be delayed, revised by the exchanges, or contain errors; figures sourced from third-party feeds and corporate disclosures may not always be current. Past performance is not indicative of future results, and equity investments carry the risk of capital loss. Before acting on anything you read here, please consult a SEBI-registered financial advisor and read all scheme-related documents carefully.